Background Image
Table of Contents Table of Contents
Previous Page  54 / 76 Next Page
Information
Show Menu
Previous Page 54 / 76 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 2, March/April 2017

120

AFRICA

Results

Demographic characteristics and clinical features of the patients

with aortic dilatation who underwent CPB and isolated CABG

surgery are summarised in Table 1. No statistically significant

differences were found between the groups for demographic and

clinical characteristics (

p

>

0.05).

The mean number of grafts used in the CABG operation

was calculated for group 1 [3.6

±

0.9 (median: 4; range: 1–6)]

and group 2 [1.5

±

0.5; (median: 1; range: 1–2)]. A statistically

significant intergroup difference was found (

p

=

0.0001).

Mean aortic cross-clamping durations were 54.9

±

11.5 min

(median: 65.5, range: 23–76) in group 1 and 26.7

±

6.4 min

(median: 25, range: 18–35) in group 2. A statistically significant

intergroup difference was found between the groups (

p

=

0.0001).

Mean CPB durations were 82.8

±

14.3 min (median: 84,

range: 39–109) in group 1 and 46.7

±

6.3 min (median: 46, range:

35–58) in group 2 (

p

=

0.0001). Total mean intubation times were

5.6

±

1.9 hours (median: 5, range: 3–14) in group 1 and 5.5

±

1.2 hours (median: 5, range: 4–12) in group 2. Mean duration

of stay in the postoperative intensive care unit was 29.3

±

17.1

hours (median: 21, range: 17–88) in group 1 and 29.7

±

15.3

hours (median: 22, range: 17–71) in group 2, with no significant

intergroup differences (

p

=

0.53).

Mean hospital stay of the patients was 6.1

±

1.6 days (median:

5, range: 5–12) in group 1 and 5.8

±

1.1 days (median: 5, range:

5–9) in group 2 with no significant intergroup differences (

p

=

0.83). In group 1, 48 (42.2%) and in group 2, 35 (44.9%) patients

required transfusion of blood and blood products during the

postoperative period, with no statistically significant difference

between the groups (

p

=

0.70). The mean total amount of

postoperative drainage was 348

±

169 ml (median: 300, range:

150–1100) in group 1 and 335

±

125 ml (median: 300, range:

150–700) in group 2, with no statistically significant intergroup

difference (

p

=

0.93).

Changes in the aortic root and ascending aortic diameter over

three years and analysis of this change are shown in Table 2. No

statistically significant intergroup difference was seen at the level

of the aortic annulus (Fig. 1) (

p

=

0.22,

p

=

0.25 and

p

=

0.13,

respectively). Annual changes in aortic diameter were found to

be extremely significantly different in both groups (

p

=

0.0001).

However, when mean differences in diameters were analysed

by year, no statistically significant intergroup difference was

detected (

p

=

0.21 and

p

=

0.37, respectively).

Mean values of aortic diameter at the level of the sinus of

Valsalva were not significantly different between the groups (Fig.

2) (

p

=

0.53,

p

=

0.37 and

p

=

0.30, respectively). However, annual

increases in diameter were found to be extremely significantly

different in both groups (

p

=

0.0001 and

p

=

0.0001, respectively).

The mean difference in diameter one year postoperatively

Table 1. Demographic and clinical characteristics of the patients

Group 1

(

n

=

114)

Presence of proxi-

mal anastomosis

Group 2

(

n

=

78)

Absence of proxi-

mal anastomosis

p

-value

Mean age (years)

(median, range)

63.0

±

9.2

(63, 42–80)

61.0

±

9.3

(61, 42–80)

0.12**

Male,

n

(%)

93 (60.4)

61 (39.6)

0.56*

Female,

n

(%)

21 (55.3)

17 (44.7)

0.45*

Ejection fraction (%)

(median, range)

53.5

±

10.2

(55, 30–70)

53.7

±

10.5

(55, 30–70)

0.91**

Hypertension,

n

(%)

28 (24.6)

27 (34.6)

0.13*

Diabetes mellitus,

n

(%)

43 (37.7)

37 (47.4)

0.18*

Smoking status,

n

(%)

34 (29.8)

19 (24.4)

0.41*

Hyperlipidemia,

n

(%)

44 (38.6)

34 (43.6)

0.49*

COPD,

n

(%)

11 (9.6)

5 (6.4)

0.43*

Pre-operative CRF,

n

(%)

6 (3.3)

2 (2.6)

0.48***

Peripheral artery disease,

n

(%)

8 (7.0)

3 (3.8)

0.53***

History of stroke,

n

(%)

7 (6.1)

2 (2.6)

0.32***

Previous myocardial infarction,

n

(%)

30 (26.3)

23 (29.5)

0.63*

Alcohol use,

n

(%)

15 (13.2)

8 (8.3)

0.54*

*Pearson’s chi-squared test; **Mann–Whitney

U

-test; ***Fisher’s exact test.

COPD

=

chronic obstructive pulmonary disease; CRF

=

chronic renal failure.

Table 2. Comparison of transthoracic echocardiography

measurements and annual differences

Group 1

(

n

=

114)

Presence of

proximal

anastomosis

Group 2

(

n

=

78)

Absence of

proximal

anastomosis

p

-value

Pre-operative annulus diameter

(mm) (median, range)

24.2

±

2.8

(24, 19–29)

23.7

±

3.1

(24, 18–31)

0.22

a

1st year annulus diameter (mm)

(median, range)

24.6

±

2.7

(25, 20–30)

24.2

±

2.9

(24, 19–31)

0.25

a

3rd year annulus diameter (mm)

(median, range)

25.6

±

2.8

(26, 21–31)

25.0

±

2.8

(25, 20–32)

0.13

a

p-v

alue

0.0001

b

0.0001

b

1st year annulus diameter difference

(mm) (median, range)

0.37

±

0.50

(0, 0–2)

0.46

±

0.53

(0, 0–2)

0.21

a

3rd year annulus diameter difference

(mm) (median, range)

1.37

±

0.55

(1, 1–3)

1.27

±

0.70

(1, 0–3)

0.37

a

p-v

alue

0.0001

b

0.0001

b

Pre-operative sinus of Valsalva

diameter (mm) (median, range)

37.2

±

1.6

(37, 34–40)

37.1

±

1.6

(37, 34–41)

0.53

a

1st year sinus valsalva diameter

(mm) (median, range)

38.0

±

1.7

(38, 35–41)

37.8

±

1.6

(38, 35–42)

0.37

a

3rd year sinus of Valsalva diameter

(mm) (median, range)

38.8

±

1.6

(39, 36–42)

38.5

±

1.7

(39, 35–42)

0.30

a

p-v

alue

0.0001

b

0.0001

b

1st year sinus of Valsalva diameter

difference (mm) (median, range)

0.79

±

0.43

(1, 0–2)

0.76

±

0.49

(1, 0–2)

0.57

a

3rd year sinus of Valsalva diameter

difference (mm) (median, range)

1.63

±

0.49

(2, 1–2)

1.45

±

0.53

(1, 1–3)

0.01

a

p-v

alue

0.0001

b

0.0001

b

Pre-operative STJ diameter (mm)

(median, range)

39.1

±

1.1

(39, 33–41)

38.9

±

1.6

(39, 36–42)

0.08

a

1st year STJ diameter (mm) (medi-

an, range)

40.3

±

1.1

(40, 37–42)

39.7

±

1.6

(39.5, 36–43)

0.002

a

3rd year STJ diameter (mm) (medi-

an, range)

41.4

±

1.2

(41.5, 38–44)

40.3

±

1.7

(40, 37–45)

0.0001

a

p-v

alue

0.0001

b

0.0001

b

1st year STJ diameter difference

(mm) (median, range)

0.99

±

0.36

(1, 0–2)

0.76

±

0.49

(1, 0–2)

0.0001

a

3rd year STJ diameter difference

(mm) (median, range)

2.21

±

0.66

(2, 0–3)

1.35

±

0.88

(1, 0–3)

0.0001

a

p-v

alue

0.0001

b

0.0001

b

Pre-operative ascending aorta diam-

eter (mm) (median, range)

41.5

±

1.3

(41, 40–45)

41.6

±

1.6

(41, 40–45)

0.79

a

1st year ascending aorta diameter

(mm) (median, range)

43.0

±

1.5

(43, 40–48)

42.1

±

1.5

(42, 40–45)

0.0001

a

3rd year ascending aorta diameter

(mm) (median, range)

44.3

±

1.6

(44, 42–49)

42.9

±

1.6

(43, 40–46)

0.0001

a

p-v

alue

0.0001

b

0.0001

b

1st year ascending aorta diameter

difference (mm) (median, range)

1.51

±

0.76

(2, 0–3)

0.58

±

0.57

(1, 0–2)

0.0001

a

3rd year ascending aorta diameter

difference (mm) (median, range)

2.77

±

0.95

(3, 1–5)

1.32

±

0.57

(1, 0–3)

0.0001

a

p-v

alue

0.0001

b

0.0001

b

a

Mann–Whitney

U

-test;

b

Friedman

S

-test; STJ

=

sinotubular junction.